Generic ADHD Med Hits Market Early

Adderall XR now available in generic versions.

Teva, owner of Barr Pharmaceuticals, is now selling generic versions of Shire's Adderall XR. The patent on the drug is not set to expire until 2018, but due to a patent litigation and licensing settlement, the generics are now available.

The generic capsules will be offered in doses ranging from 5- to 30-mg doses.

Read more about the settlement and generic options.

Copyright © 1998 - 2013 New Hope Media LLC. All rights reserved. Your use of this site is governed by our
Terms of Service (http://www.additudemag.com/adhd/terms.html) and
Privacy Policy (http://www.additudemag.com/adhd/privacy.html).
ADDitude does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only.
See additional information at http://www.additudemag.com/adhd/disclaimer.html
New Hope Media, 39 W. 37th Street, 15th Floor, New York, NY 10018

Source: Generic ADHD Med Hits Market Early